Prolonged Bradycardia and Hypotension Following Guanfacine Extended Release Overdose
نویسندگان
چکیده
منابع مشابه
Severe bradycardia and prolonged hypotension in ciguatera.
Ciguatera results when ciguatoxin-contaminated coral reef fish from tropical or subtropical waters are consumed. The clinical features that present in affected persons are mainly gastrointestinal, neurological, general, and much less commonly, cardiovascular. We report the case of a 50-year-old man who developed the characteristic combination of acute gastrointestinal and neurological symptoms ...
متن کاملA Case Report of Hypotension and Bradycardia Associated with Immediate-Release Diltiazem Overdose
A 31-year-old female had attempted suicide with 56 diltiazem 30 mg immediate-release (IR) tablets of her father’s prescription and was admitted into emergency department after one hour of ingestion. First vital signs revealed temperature of 36.2 , blood pressure of 58/27 mmHg and pulse of 7 °C 1 beats/min. The electrocardiogram showed junctional bradycardia. She was given the following treatmen...
متن کاملProlonged Q-T interval following astemizole overdose.
Astemizole overdose has been reported to cause torsades-de-pointes and in the present case it caused prolongation of the Q-T interval. Astemizole overdoses should be managed in a similar way to overdose with other cardiotoxic drugs.
متن کاملPharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
BACKGROUND In clinical practice, α₂-adrenoceptor agonists have been adjunctively administered with psychostimulants for the treatment of attention-deficit/hyperactivity disorder (ADHD). Two studies have examined the adjunctive use of guanfacine extended release (GXR, Intuniv®; Shire Development LLC, Wayne, PA, USA) with psychostimulants in children and adolescents with a suboptimal response to ...
متن کاملPharmacokinetics of Coadministration of Guanfacine Extended Release and Methylphenidate Extended Release
BACKGROUND α2-Adrenoceptor agonists are used adjunctively to psychostimulants in treating attention-deficit/hyperactivity disorder (ADHD) when psychostimulants alone do not sufficiently reduce symptoms. However, data on the pharmacokinetic profiles and safety of combination treatments in ADHD are needed. OBJECTIVE The primary objective of this study was to evaluate the pharmacokinetic profile...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Child and Adolescent Psychopharmacology
سال: 2014
ISSN: 1044-5463,1557-8992
DOI: 10.1089/cap.2014.0022